Transaction in Own Shares

Summary by AI BETAClose X

CT Private Equity Trust PLC has purchased a total of 35,000 ordinary shares on the London Stock Exchange. On July 10, 2026, 7,340 shares were bought at 489.73p each, followed by a purchase of 27,660 shares on July 15, 2026, at 498.40p each. These shares will be held in treasury, bringing the total held to 2,473,491, with 71,467,938 ordinary shares now in issue, which serves as the denominator for shareholder notification calculations.

Disclaimer*

CT Private Equity Trust PLC
15 July 2026
 

 

 

 

15 July 2026

 

CT PRIVATE EQUITY TRUST PLC

 

LEI: 2138009FW98WZFCGRN66

 

 

TRANSACTION IN OWN SHARES

 

 

In accordance with Listing Rule 12.4.6, CT Private Equity Trust PLC (the Company) announces it has purchased the following number of its ordinary shares of 1 pence each on the London Stock Exchange through Singer Capital Markets.

 

Ordinary Shares:

 

Date of purchase:

10 July 2026

15 July 2026

Number of ordinary shares purchased:

7,340

27,660

Lowest price per share:

489.73p

498.40p

Highest price per share:

489.73p

498.40p

Trading venue:

London

London

Weighted average price per trading venue:

489.73p

498.40p

                                                                                                          

 

The Company intends to hold the purchased shares in treasury.

 

Following the above transactions, the Company holds 2,473,491 of its ordinary shares in treasury and has 71,467,938 ordinary shares in issue (excluding treasury shares).

 

Therefore, the total number of voting rights in the Company is now 71,467,938. The above figure (71,467,938) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

For further information please contact:

 

Andrew Carnwath (Investment Manager)

0131 573 8283

Scott McEllen (Company Secretary)

0131 573 8372

andrew.carnwath@columbiathreadneedle.com/ scott.mcellen@columbiathreadneedle.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings